Group 1 - The core point of the announcement is that the controlling shareholder and general manager of Auhua Endoscopy plans to reduce their holdings by up to 2,600,000 shares, which represents a maximum of 1.93% of the company's total share capital [1] - The reduction will occur through two methods: a maximum of 1,346,600 shares (1.00% of total share capital) via centralized bidding within three months after a 15 trading day period from the announcement, and a maximum of 1,253,400 shares (0.93% of total share capital) through block trading under the same timeline [1] - For the fiscal year 2024, Auhua Endoscopy's revenue composition is heavily weighted towards medical devices, accounting for 99.73% of total revenue, with other businesses contributing only 0.27% [1] Group 2 - As of the latest report, Auhua Endoscopy has a market capitalization of 6.4 billion yuan [2]
澳华内镜：总经理顾小舟计划减持不超过260万股